7677827

Source:http://linkedlifedata.com/resource/pubmed/id/7677827

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035078, umls-concept:C0035086, umls-concept:C0044410, umls-concept:C0205081, umls-concept:C0205296, umls-concept:C0547040, umls-concept:C0750729, umls-concept:C1280500
pubmed:issue	6976
pubmed:dateCreated	1995-3-30
pubmed:abstractText	To determine whether alfacalcidol--used in management of overt renal bone disease--may safely prevent renal bone disease when used earlier in course of renal failure.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-1244564, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-1331788, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-1464362, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-1580587, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-2205749, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-2709685, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-2993340, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3044329, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3053038, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3455637, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3624408, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3760186, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3840080, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3858880, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-3917782, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4087699, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4121843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4172083, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4359739, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4553202, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4578017, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-4696838, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-504552, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-6174656, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-6547151, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-682426, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-723151, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-7613376, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-7677873, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-850517, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-940274, http://linkedlifedata.com/resource/pubmed/commentcorrection/7677827-940279
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1-hydroxycholecalciferol, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxycholecalciferols, http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0959-8138
pubmed:author	pubmed-author:BenetonM NMN, pubmed-author:BrownC BCB, pubmed-author:FaireyI TIT, pubmed-author:HamdyN ANA, pubmed-author:JordansJ GJG, pubmed-author:JosseSS, pubmed-author:JuttmannJ RJR, pubmed-author:KanisJ AJA, pubmed-author:LinsR LRL, pubmed-author:MeyrierAA
pubmed:issnType	Print
pubmed:day	11
pubmed:volume	310
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	358-63
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:7677827-Adolescent, pubmed-meshheading:7677827-Adult, pubmed-meshheading:7677827-Aged, pubmed-meshheading:7677827-Aged, 80 and over, pubmed-meshheading:7677827-Bone and Bones, pubmed-meshheading:7677827-Calcium, pubmed-meshheading:7677827-Double-Blind Method, pubmed-meshheading:7677827-Female, pubmed-meshheading:7677827-Humans, pubmed-meshheading:7677827-Hydroxycholecalciferols, pubmed-meshheading:7677827-Hypercalcemia, pubmed-meshheading:7677827-Male, pubmed-meshheading:7677827-Middle Aged, pubmed-meshheading:7677827-Parathyroid Hormone, pubmed-meshheading:7677827-Prospective Studies, pubmed-meshheading:7677827-Renal Insufficiency, pubmed-meshheading:7677827-Renal Osteodystrophy
pubmed:year	1995
pubmed:articleTitle	Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.
pubmed:affiliation	Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial